Barclays Lowers Colgate-Palmolive (NYSE:CL) Price Target to $83.00

Colgate-Palmolive (NYSE:CL) had its target price decreased by research analysts at Barclays from $96.00 to $83.00 in a note issued to investors on Friday,Benzinga reports. The firm presently has an “equal weight” rating on the stock. Barclays‘s target price would suggest a potential downside of 6.53% from the company’s previous close.

A number of other equities research analysts have also weighed in on CL. Piper Sandler lowered their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a report on Monday, January 6th. Stifel Nicolaus downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lowered their price target for the stock from $105.00 to $101.00 in a research note on Monday, October 28th. StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. UBS Group lowered their target price on Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating for the company in a research note on Thursday. Finally, TD Cowen reduced their price target on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a research report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $101.11.

Colgate-Palmolive Stock Performance

Shares of NYSE CL opened at $88.79 on Friday. The stock’s 50-day moving average is $92.20 and its 200 day moving average is $97.74. The stock has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a P/E/G ratio of 3.01 and a beta of 0.44. Colgate-Palmolive has a 1-year low of $79.69 and a 1-year high of $109.30. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 0.37% of the stock is owned by insiders.

Hedge Funds Weigh In On Colgate-Palmolive

Large investors have recently made changes to their positions in the business. Apeiron RIA LLC grew its stake in shares of Colgate-Palmolive by 5.1% in the 4th quarter. Apeiron RIA LLC now owns 7,745 shares of the company’s stock worth $704,000 after buying an additional 379 shares during the last quarter. Whalen Wealth Management Inc. bought a new stake in Colgate-Palmolive in the fourth quarter worth $291,000. Wesbanco Bank Inc. grew its stake in shares of Colgate-Palmolive by 1.7% in the fourth quarter. Wesbanco Bank Inc. now owns 15,066 shares of the company’s stock worth $1,370,000 after acquiring an additional 250 shares during the last quarter. Janney Montgomery Scott LLC increased its holdings in shares of Colgate-Palmolive by 2.2% during the fourth quarter. Janney Montgomery Scott LLC now owns 387,487 shares of the company’s stock valued at $35,227,000 after acquiring an additional 8,293 shares in the last quarter. Finally, Atomi Financial Group Inc. raised its position in shares of Colgate-Palmolive by 6.5% in the 4th quarter. Atomi Financial Group Inc. now owns 6,489 shares of the company’s stock worth $590,000 after purchasing an additional 394 shares during the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.